Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Ting Li Ong

1PUBLICATIONS

9CO-AUTHORS

Molecular targets

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (1)

Sort by Publication Date:

|Aug 29, 2024

Glutathione-S-Transferase Theta 2 (GSTT2) Modulates the Response to Bacillus Calmette-Guérin Immunotherapy in Bladder Cancer Patients.

Juwita N Rahmat, Sin Mun Tham, Ting Li Ong

Pageof 1

Frequent Collaborators

1 joint publications

Juwita N Rahmat

1 joint publications

Sin Mun Tham

1 joint publications

Yew Koon Lim

1 joint publications

Mugdha Vijay Patwardhan

1 joint publications

Revathi Kamaraj

1 joint publications

Yiong Huak Chan

1 joint publications

Tsung Wen Chong

1 joint publications

Kesavan Esuvaranathan

1 joint publications

Ratha Mahendran

Frequent Collaborators

1 joint publications

Juwita N Rahmat

1 joint publications

Sin Mun Tham

1 joint publications

Yew Koon Lim

1 joint publications

Mugdha Vijay Patwardhan

Top Related Videos

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Published on : Oct 30, 2013

See more related videos

Top Related Videos

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development

Published on : Oct 30, 2013

See more related videos